Galderma Launches “Scratch Resistance” DTC Nemolizumab Campaign
Galderma is launching “Scratch Resistance,” its new broadcast advertisement and first Direct-to-Consumer (DTC) multichannel campaign for nemolizumab-ilto (Nemluvio).
Category: Headlines in Dermatology